Your browser doesn't support javascript.
loading
Treatment guidelines in ovarian cancer
Poveda Velasco, A; Casado Herráez, A; Cervantes Ruipérez, A; Gallardo Rincón, D; García García, E; González Martín, A; López García, G; Mendiola Fernández, C; Ojeda González, B.
Afiliação
  • Poveda Velasco, A; Instituto Valenciano de Oncología. Valencia. Spain
  • Casado Herráez, A; Instituto Valenciano de Oncología. Valencia. Spain
  • Cervantes Ruipérez, A; Instituto Valenciano de Oncología. Valencia. Spain
  • Gallardo Rincón, D; Instituto Valenciano de Oncología. Valencia. Spain
  • García García, E; Instituto Valenciano de Oncología. Valencia. Spain
  • González Martín, A; Instituto Valenciano de Oncología. Valencia. Spain
  • López García, G; Instituto Valenciano de Oncología. Valencia. Spain
  • Mendiola Fernández, C; Instituto Valenciano de Oncología. Valencia. Spain
  • Ojeda González, B; Instituto Valenciano de Oncología. Valencia. Spain
Clin. transl. oncol. (Print) ; 9(5): 308-316, mayo 2007. ilus, tab
Article em En | IBECS | ID: ibc-123311
Biblioteca responsável: ES1.1
Localização: BNCS
ABSTRACT
National and international specialists have met with the aim of writing down the guidelines for the treatment of epithelial ovarian cancer (in the Spanish Castilian language). These guidelines are based on the International Consensus that was published in English in the Annals of Oncology in 2005. This condition is the leading cause of death from gynaecological cancer in western countries. Its low rate of survival, barely 30% at 5 years, is above all due to late diagnosis and inappropriate surgery, so emphasis is put on these aspects. After describing the methodology for early detection and a scheme of surgical diagnostic procedures in view of the staging of an ovarian mass, the following therapeutic strategies will be recommended cytoreductive surgery together with platinum chemotherapy under normal conditions, and also in the case of relapse. Likewise, very recent models of treatment focused on molecular targets are presented, and a broad section on methodology of clinical assays. As for this, co-operation among groups is crucial in order to make the conclusions of these studies valid for the development of new therapies (AU)
Assuntos
Buscar no Google
Coleções: 06-national / ES Base de dados: IBECS Assunto principal: Neoplasias Ovarianas / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Clin. transl. oncol. (Print) Ano de publicação: 2007 Tipo de documento: Article
Buscar no Google
Coleções: 06-national / ES Base de dados: IBECS Assunto principal: Neoplasias Ovarianas / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Clin. transl. oncol. (Print) Ano de publicação: 2007 Tipo de documento: Article
...